Panacea Biotec Ltd

Panacea Biotec Legal & Regulatory

Panacea Biotec received four income tax demand orders totaling ₹9.82 Crore for alleged misreporting. The company contests this as non-maintainable and plans to appeal.

Value

₹9.82 Cr

Panacea Biotec Other Announcement

Panacea Biotec sent reminder letters to physical shareholders requesting PAN and KYC updates per SEBI circulars. No transaction or business event is involved.

Panacea Biotec Annual General Meeting

Panacea Biotec Limited issued the notice for its 42nd Annual General Meeting scheduled for September 29, 2026, via video conferencing. Shareholders can participate through remote e-voting.

Panacea Biotec Other Announcement

Panacea Biotec Limited has submitted its monthly share dematerialization report for August 2026. This is a routine regulatory compliance filing under SEBI Regulation 74(5).

Panacea Biotec Capital Structure Change

Nosheen Sheikh, an employee's immediate relative, sold 3,000 equity shares of Panacea Biotec Ltd for ₹12.29 Lakh in a market sale.

Value

₹0.12 Cr

Panacea Biotec Q1 FY27 Results: Net Profit ₹2.2 Cr, Down 45.0% YoY

Panacea Biotec Ltd reported revenue from operations of ₹199.6 Cr (+19.7% YoY) and net profit of ₹2.2 Cr (-45.0% YoY) for Q1 FY27.

Key figure

Net profit ₹2.2 Cr · -45.0% YoY

Panacea Biotec Board Meeting Date

Panacea Biotec will hold a board meeting on August 13, 2026, to approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.